A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Clinical trial NCT01440088 · COMPLETED
Trial details
- NCT number
- NCT01440088
- Sponsor
- Threshold Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2015-12-01
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.